SB 160 — Regards prescription drugs and medication switching
Last action — Introduced
-
✓Introduced
-
✓In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill has passed the Senate. Introduced April 01, 2025. It now moves to the second chamber.
Next likely step: consideration and a floor vote in the House.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Passed Senate
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 D).
-
Mixed recorded votes
2 passed, 1 failed in recorded votes so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
The bill addresses regulations for prescription drugs and medication switching.
This measure establishes guidelines related to prescription drugs and the practice of switching medications. It aims to create a framework for how medication changes are handled.
Summary
To enact section 3902.65 of the Revised Code regarding prescription drugs and medication switching.
Bill Text
What changed in the latest version
6 added · 5 removedPlain-language change summary
The latest version of Bill SB 160 now includes a list of senators who are cosponsoring the legislation, highlighting the support it has received from multiple lawmakers. Additionally, references to the committee report have been removed, which streamlines the text and focuses more on the bill itself. This change is significant as it strengthens the bill's visibility and emphasizes bipartisan support, making it clearer for the public and lawmakers alike.
As ReportedPassed by the Senate Financial Institutions, Insurance and Technology Committee 136th General Assembly Regular Session Sub.
160 2025-2026 Senators Liston, Johnson ToCosponsors: enact section 3902.65 of the Revised Code 1 regarding prescription drugs and medication 2 switching under health benefit plans.
Senators Antonio, Blackshear, Cirino, Craig, DeMora, Hicks-Hudson, Patton, Reineke, Reynolds, Schaffer To enact section 3902.65 of the Revised Code 1 regarding prescription drugs and medication 2 switching under health benefit plans.
15 (B) Subject to divisions (C), (D), and (E) of this 16 section, a health plan issuer shall not do any of the following 17 duringSub. a health benefit plan year:
18 Sub.
160 Page 2 As ReportedPassed by the Senate Financialduring Institutions, Insurance and Technology Committee (1) Increase a coveredhealth person'sbenefit costplan sharingyear: with respect 19 to a drug;
18 (1) Increase a covered person's cost sharing with respect 19 to a drug;
44 (2) A health plan issuer permitting a covered person to 45 use the generically equivalent drug or interchangeable 46 Sub.
160 Page 3 As ReportedPassed by the Senate Financial(2) Institutions,A Insurancehealth andplan Technologyissuer Committeepermitting a covered person to 45 use the generically equivalent drug or interchangeable 46 biological product instead of the prescribed drug;
If a health plan issuer seeks to 69 take an action described in division (B) of this section for a 70 drug subject to such a price increase, it shall maintain 71 supporting documentation that justifies the action for a period 72 of three years after the effective date of the price increase 73 andSub. shall provide the supporting documentation to the department 74 of insurance upon the department's request.
75 Sub.
160 Page 4 As ReportedPassed by the Senate Financial Institutions, Insurance and Technology Committee (F) A violation of this section shall beprovide consideredthe ansupporting 76documentation unfairto and deceptive practice in the businessdepartment 74 of insurance forupon 77 purposes of section 3901.21 of the Reviseddepartment's Code.request.
75 (F) A violation of this section shall be considered an 76 unfair and deceptive practice in the business of insurance for 77 purposes of section 3901.21 of the Revised Code.
View plain text versions (3)
- As Passed by the Senate View text Current pdf
- Reported As Reported by the Senate Financial Institutions, Insurance and Technology Committee pdf
- Introduced As Introduced pdf
Action History
-
As Passed by the Senate
Sponsors
- Beth Liston · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 133 not signed on
Sponsors (1)
- Beth Liston Democratic
Co-sponsors (0)
None.
Not signed on (133)
133 members have not signed on to this bill.
Show all 133 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Republican | 24 | 0 | 0 | 0 |
| Democratic | 9 | 0 | 0 | 0 |
| Total | 33 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (33)
| Member | Party | Vote |
|---|---|---|
| Beth Liston | Democratic | Yea |
| Casey Weinstein | Democratic | Yea |
| Catherine D. Ingram | Democratic | Yea |
| Hearcel F. Craig | Democratic | Yea |
| Kent Smith | Democratic | Yea |
| Nickie J. Antonio | Democratic | Yea |
| Paula Hicks-Hudson | Democratic | Yea |
| William P. DeMora | Democratic | Yea |
| Willis E. Blackshear, Jr. | Democratic | Yea |
| Al Cutrona | Republican | Yea |
| Al Landis | Republican | Yea |
| Andrew O. Brenner | Republican | Yea |
| Bill Reineke | Republican | Yea |
| Brian M. Chavez | Republican | Yea |
| George F. Lang | Republican | Yea |
| Jane M. Timken | Republican | Yea |
| Jerry C. Cirino | Republican | Yea |
| Kristina D. Roegner | Republican | Yea |
| Kyle Koehler | Republican | Yea |
| Louis W. Blessing, III | Republican | Yea |
| Mark Romanchuk | Republican | Yea |
| Michele Reynolds | Republican | Yea |
| Nathan H. Manning | Republican | Yea |
| Rob McColley | Republican | Yea |
| Sandra O'Brien | Republican | Yea |
| Shane Wilkin | Republican | Yea |
| Stephen A. Huffman | Republican | Yea |
| Steve Wilson | Republican | Yea |
| Susan Manchester | Republican | Yea |
| Terry Johnson | Republican | Yea |
| Theresa Gavarone | Republican | Yea |
| Thomas F. Patton | Republican | Yea |
| Tim Schaffer | Republican | Yea |
Roll call published as PDF — view source.
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Republican | 6 | 0 | 0 | 0 |
| Democratic | 3 | 0 | 0 | 0 |
| Total | 9 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (9)
| Member | Party | Vote |
|---|---|---|
| Beth Liston | Democratic | Yea |
| Hearcel F. Craig | Democratic | Yea |
| William P. DeMora | Democratic | Yea |
| Brian M. Chavez | Republican | Yea |
| George F. Lang | Republican | Yea |
| Louis W. Blessing, III | Republican | Yea |
| Nathan H. Manning | Republican | Yea |
| Steve Wilson | Republican | Yea |
| Thomas F. Patton | Republican | Yea |
Subjects
Frequently asked questions
- What does SB 160 do?
- To enact section 3902.65 of the Revised Code regarding prescription drugs and medication switching.
- Who sponsors SB 160?
- SB 160 is sponsored by Beth Liston (Democratic).
- What is the current status of SB 160?
- This bill has passed the Senate. Introduced April 01, 2025. It now moves to the second chamber.
- Where can I track SB 160?
- Track SB 160 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 160
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 160
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →